-The Economic Times The government is ready to give up its monopoly over coal mining to meet the requirements of the economy, if BJP supports a long-pending legislation to amend the Coal Mine Nationalisation Act (CMNA). "We are ready to take up the bill and open up the coal sector to increase production. This is the only way forward and there is a consensus within the government on this. Once BJP comes...

-The Hindu Even as UPA-II and the Opposition are bracing themselves for confrontation in and outside Parliament over coal blocks allocations during 2004-09, the Prime Minister’s Office and the Coal Ministry are ready with their defence: the policy imperative was to augment production by supplementing Coal India’s efforts with private participation within the parameters of law. According to documents available with The Hindu , the arguments, which the government hopes to present...

-The Economic Times The economic and social impact of reduction in petroleum subsidies in India will be much lower than perceived if a cash transfer system for directly subsidising vulnerable consumers is successfully implemented, studies commissioned by the Geneva-based International Institute for Sustainable Development have said. The government must, however, dismantle subsidies in a calibrated manner as vulnerable consumers will be able to adjust better if the under-recoveries are gradually eliminated, cautioned...

-Frontline A recession-hit world is only just waking up to the prospect of the coming food crisis resulting in a period of political turmoil with unexpected consequences.  For the third time in five years, the world is braced for another food crisis. Bad weather conditions are leading to projections of major production shortfalls in some of the world’s leading food suppliers. Substantially reduced access and sharp price increases are, therefore, expected to...

-The Economic Times Drug Companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials.  According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...